$56.42 -$0.69 (-1.2%)

04:30 PM EST on 01/17/20

Arrowhead Pharmaceuticals Inc Com (NASDAQ:ARWR)

CAPS Rating: 4 out of 5

A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.

Current Price $56.42 Mkt Cap $5.7B
Open $57.69 P/E Ratio 77.90
Prev. Close $56.42 Div. (Yield) $0.00 (0.0%)
Daily Range $56.11 - $57.69 Volume 1,531,453
52-Wk Range $54.19 - $64.00 Avg. Daily Vol. 2,719,373

Caps

How do you think NASDAQ:ARWR will perform against the market?

Add Stock to CAPS Watchlist

All Players

218 Outperform
18 Underperform
 

All-Star Players

43 Outperform
10 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NASDAQ:ARWR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Bigsef77 (68.94)
Submitted September 06, 2018

Arrowhead Pharmaceuticals stock rockets 30% after upbeat trial data prompts analyst upgrade,MarketWatch•September 6, 2018MARKET PULSE Shares of Arrowhead Pharmaceuticals Corp. (arwr) rocketed 30% toward a 4 1/2-year high in premarket trade Thursday,… More

TMFBlacknGold (96.65)
Submitted December 13, 2019

Short-term CAPS pick, would like to green thumb at a much lower market cap...From 12/04/2019: "Arrowhead Pharmaceuticals ended September with more than $258 million in cash and short-term investments. The recent public stock offering will nearly… More

Recent Community Commentary

Read the most recent pitches from players about ARWR.

Recs

1
Member Avatar TMFBlacknGold (96.65) Submitted: 12/13/2019 10:25:32 AM : Underperform Start Price: $70.74 NASDAQ:ARWR Score: +27.86

Short-term CAPS pick, would like to green thumb at a much lower market cap...

From 12/04/2019:

"Arrowhead Pharmaceuticals ended September with more than $258 million in cash and short-term investments. The recent public stock offering will nearly double the company's financial flexibility. That should be comforting to investors, as it de-risks drug development from a pipeline buzzing with activity, but a market cap of $6 billion is certainly generous for the RNAi developer -- barring an acquisition, of course."

https://www.fool.com/investing/2019/12/04/heres-why-arrowhead-pharmaceuticals-is-tumbling-to.aspx

Recs

3
Member Avatar Bigsef77 (68.94) Submitted: 9/6/2018 11:23:29 AM : Outperform Start Price: $1.52 NASDAQ:ARWR Score: +3,572.84

Arrowhead Pharmaceuticals stock rockets 30% after upbeat trial data prompts analyst upgrade
,MarketWatch•September 6, 2018

MARKET PULSE Shares of Arrowhead Pharmaceuticals Corp. (arwr) rocketed 30% toward a 4 1/2-year high in premarket trade Thursday, after upbeat results of the company's treatment for chronic hepatitis B prompted an upgrade at B.

Recs

0
Member Avatar Quickcard (< 20) Submitted: 10/10/2017 5:07:56 PM : Outperform Start Price: $4.02 NASDAQ:ARWR Score: +1,273.02

Pharma companies with what are doing research with verifiable positive results in treatment for especially intractable medical conditions seem to be on a roll. I don't see this should not continue, especially as DNA/RNA research is reaching new highs at the same time.

Leaderboard

Find the members with the highest scoring picks in ARWR.

Score Leader

mistermiranga

mistermiranga (99.75) Score: +3,762.61

ZZ Langerhans has left the building. trying to grab his own bottom now. I am king!

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. mistermiranga 99.75 12/1/2016 Outperform 5Y $1.41 +3,915.66% +50.87% +3,864.79 0 Comment
Bigsef77 68.94 4/25/2017 5/9/2018 Outperform 3Y $1.52 +3,612.09% +39.24% +3,572.84 1 Comment
KidJones 34.01 4/22/2013 Outperform 5Y $1.78 +3,069.66% +113.15% +2,956.51 0 Comment
whoodatstockhot 85.12 7/8/2013 Outperform 5Y $2.02 +2,693.07% +102.64% +2,590.43 0 Comment
EvilEmpire 30.45 2/28/2013 Outperform 5Y $2.20 +2,464.55% +118.60% +2,345.95 0 Comment
MFBurritoSquat 92.43 12/19/2012 Outperform 3M $2.23 +2,430.04% +128.17% +2,301.88 0 Comment
hayrettin 70.97 8/24/2017 Outperform 5Y $2.50 +2,161.32% +35.79% +2,125.54 0 Comment
AJL7 < 20 2/3/2016 Outperform 5Y $3.26 +1,630.67% +73.48% +1,557.20 0 Comment
beecha < 20 9/19/2017 Outperform 5Y $3.35 +1,584.18% +32.82% +1,551.36 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 < 20 9/13/2017 Outperform 5Y $3.42 +1,552.12% +32.84% +1,519.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARWR.